Streetbeat News

Stock Prices

SDOT

Sadot Group's stock price has declined following the release of their Q3 financial results, which showed a year-over-year decrease.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:53 pm

AEY

ADDvantage Technologies' stock price is trading lower following the announcement of a year-over-year decline in their Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:52 pm

FHN

RBC Capital analyst Jon Arfstrom has maintained a 'Sector Perform' rating on First Horizon (NYSE:FHN) and increased the price target from $13 to $14.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:50 pm

NIO

NIO Inc (NYSE:NIO) shares rose by 7.9% to $28.82, likely due to positive sentiment from JD.com's Q3 results, which showed a slight drop in net product revenue but a 12.7% increase in net service revenues. JD's strong performance may indicate a robust online retail sector in China, potentially benefiting related industries like EV manufacturers such as NIO.

Portfolio Pulse from Henry Khederian

November 15, 2023 | 6:50 pm

DVN

RBC Capital analyst Scott Hanold has maintained a 'Sector Perform' rating on Devon Energy (NYSE:DVN) but lowered the price target from $60 to $55.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:49 pm

ELIQ

Electriq Power Holdings reported a year-over-year decrease in Q3 revenue, leading to a decline in its share price.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:47 pm

CMMB

Chemomab Therapeutics' stock is trading higher following the announcement that the FDA has granted fast track designation to its drug CM-101 for the treatment of primary sclerosing cholangitis.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:46 pm

SKIN

The Beauty Health Company's stock (SKIN) is trading lower following a downgrade by Jefferies from Buy to Hold and a significant reduction in the price target from $11 to $1.5.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:39 pm

SPRC

SciSparc shares are up following the announcement of positive topline results from a Phase IIa trial for Alzheimer's at the Sophie & Abraham Stuchynski Israeli Alzheimer's Medical Center.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:38 pm

KNTE

Kinnate Biopharma's stock price has risen following the announcement that it received a letter from Foresite Capital Management and OrbiMed Advisors expressing interest in potentially acquiring all outstanding shares of the company.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 6:35 pm